By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 



Industry
Biotechnology


Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Regeneron (REGN) And Sanofi (SNY) Announce New Positive Praluent (alirocumab) Phase 3 Data Presented At ESC Congress 2015 9/1/2015 7:30:39 AM
Regeneron (REGN) Announces Upcoming 2015 Investor Conference Presentations 8/31/2015 10:25:18 AM
Alnylam (ALNY), The Medicines Company (MDCO)'s Long-Acting Cholesterol Drug May Threaten Amgen (AMGN), Regeneron (REGN)-Sanofi (SNY)'s Blockbusters 8/31/2015 5:55:51 AM
After Sanofi (SNY) Deal Paydays, Regeneron (REGN) Expands Facilities in New York 8/25/2015 7:27:18 AM
Fight Intensifying Over Which Patients Will Get Regeneron (REGN), Sanofi (SNY)'s $15,000 a Year Cholesterol Drug 8/11/2015 6:14:34 AM
Merus Prevails in Inequitable Conduct Case Against Regeneron (REGN) 8/10/2015 9:09:27 AM
Will Regeneron (REGN)'s New Drug Praluent Break The Bank? 8/5/2015 6:47:59 AM
Regeneron (REGN) Reports Second Quarter 2015 Financial And Operating Results 8/4/2015 7:18:14 AM
Regeneron (REGN)'s George Yancopoulos Becomes Pharma's First Billionaire R&D Chief 7/29/2015 6:52:08 AM
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal 7/28/2015 5:48:51 AM
12345678910...
//-->